Nektar Therapeutics (NKTR) Stock Chart & Stock Price History $25.76 -3.92 (-13.21%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$26.00 +0.24 (+0.95%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Nektar Therapeutics Stock Price Performance The Nektar Therapeutics (NKTR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 38.49%, with a year-to-date return of 84.66%. In the past month, the stock has increased 137.33%, reflecting recent market activity. As of the latest close, Nektar Therapeutics traded at $25.76 with a market cap of $319.68 million and volume of 4.77 million shares. Five years ago, the stock traded at a split-adjusted price of $336.30, representing a 92.34% decrease over that period. At the time, it had a market cap of $4.12 billion and a volume of 57,727 shares. Receive NKTR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-11.54%1 Month Performance+137.33%3 Month Performance+132.07%Year-To-Date Performance+84.66%1 Year Performance+38.49%5 Year Performance-92.34% NKTR Stock Chart for Monday, June, 30, 2025 NKTR Chart by TradingView Nektar Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/27/2025$29.68$25.76-13.21%$29.26$25.304.77 million shs$319.68 million06/26/2025$29.12$29.68+1.92%$33.81$27.107.02 million shs$368.33 million06/25/2025$24.45$29.12+19.10%$37.38$23.3326.01 million shs$361.47 million06/24/2025$9.54$24.45+156.29%$27.68$16.5637.00 million shs$303.42 million06/23/2025$8.51$9.54+12.10%$9.75$8.351.29 million shs$118.39 million06/20/2025$8.61$8.51-1.16%$8.86$8.27370,011 shs$105.64 million06/19/2025$8.61$8.61$9.27$8.37449,582 shs$106.85 million06/18/2025$8.73$8.61-1.37%$9.27$8.37449,582 shs$106.85 million06/17/2025$9.25$8.73-5.62%$9.71$8.63382,436 shs$108.37 million06/16/2025$8.59$9.25+7.68%$9.59$7.99884,816 shs$114.82 million Get the Latest News and Ratings for NKTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/13/2025$8.76$8.59-1.94%$9.13$8.22441,266 shs$1.60 billion06/12/2025$9.55$8.76-8.27%$9.54$8.75454,010 shs$1.63 billion06/11/2025$11.35$9.55-15.86%$11.40$9.31501,403 shs$1.78 billion06/10/2025$8.79$11.35+29.12%$11.65$8.181.42 million shs$2.11 billion06/09/2025$9.99$8.79-12.01%$11.02$8.76736,268 shs$1.64 billion06/06/2025$10.12$9.99-1.30%$10.41$9.89136,263 shs$123.95 million06/05/2025$11.19$10.12-9.58%$10.58$9.56254,602 shs$125.58 million06/04/2025$11.24$11.19-0.43%$11.70$10.8066,108 shs$138.89 million06/03/2025$11.95$11.24-5.89%$12.45$11.10163,660 shs$139.49 million06/02/2025$10.85$11.95+10.06%$12.30$10.50158,047 shs$148.21 million05/30/2025$11.09$10.85-2.14%$11.25$10.09145,164 shs$134.67 million05/29/2025$10.49$11.09+5.73%$11.10$10.20125,853 shs$137.61 million Related Companies OMER Stock Chart ASMB Stock Chart CPIX Stock Chart LLY Stock Chart JNJ Stock Chart ABBV Stock Chart MRK Stock Chart PFE Stock Chart BMY Stock Chart ZTS Stock Chart Receive NKTR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NKTR) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored“Trump’s 24-Hour Profit Windows” revealedTrading legend Larry Benedict has discovered a repeating surge of $240 billion (and more)... Flowing into a...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Nektar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
